Curio Wellness, a cGMP-certified, vertically integrated cannabis company, today announced the opening of its first manufacturing and cultivation facility in Missouri.
Located in Maryland Heights, the 130,000-square-foot facility will begin manufacturing and product distribution this month. Cultivation operations will begin in the second half of the year, but the plant will create some 150 jobs in the greater St. Louis area.
According to the company, it is one of the only manufacturers in the state recommended for cGMP certification. Curio hopes to provide patients and adult-use consumers with safe, effective and reliable cannabis-based medicine and lifestyle products.
The company uses pharmaceutical-grade technology and extensively researched, patent-pending infusion methods to craft chews, vapes, tinctures, tablets and topicals.
"As the first cGMP-certified operator in Maryland, we are thrilled to bring our strict commitment to quality standards and product excellence to consumers in Missouri," said Andrew Shiang, Director of Manufacturing in Missouri. Shiang added that cGMP certification will help the company offer reliable and consistent cannabis experiences not yet available from other operators in the state.
Curio has partnered with VMO-Ops, Inc., a Missouri minority-owned business enterprise. Through the partnership, Curio will offer industry expertise and products to more than 200,000 patients and adult-use consumers statewide. Some of the products coming to Missouri include Curio’s patented Good Night Line, patent pending Terpene Chews, and GI products that are formulated to help address symptoms associated with gastrointestinal conditions.
